Pediatric Study Subjects Should Be Informed Of Enrollment Incentives
Executive Summary
Enrollment incentives should be disclosed to pediatric trial subjects as part of the assent process, FDA's pediatric advisory subcommittee recommended Nov. 15.
You may also be interested in...
Pediatric Trial Recruitment Would Be Studied By HHS Under Dodd/DeWine Bill
HHS would examine the methods used to recruit pediatric patients into clinical trials under a bill introduced by Sens. Dodd (D-Conn.) and DeWine (R-Ohio).
Pediatric Trial Recruitment Would Be Studied By HHS Under Dodd/DeWine Bill
HHS would examine the methods used to recruit pediatric patients into clinical trials under a bill introduced by Sens. Dodd (D-Conn.) and DeWine (R-Ohio).
Pediatric Safety Trials Should Not Be Limited To Sick Children, Cmte. Says
Early-phase pediatric clinical trials should not preferentially enroll hospitalized children over healthy children, members of FDA's Pediatric Advisory Subcommittee advised the agency Nov. 15.